OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience-Reference-Cited by-同舟云学术

OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience

Published:2018-06 Issue:S1 Volume:39 Page:171-172
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Vernieri Fabrizio,Paolucci Matteo,Altamura Claudia,Pasqualetti Patrizio,Mastrangelo Vincenzo,Pierangeli Giulia,Cevoli Sabina,D’Amico Domenico,Grazzi Licia

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-018-3393-3.pdf

Reference3 articles.

1. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71:559–566

2. Aurora SK, Dodick DW, Turkel CC, RE DG, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT 1 Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793–803

3. Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF, PREEMPT 2 Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30:804–814

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact;Medicine;2023-07-01

2. A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA;CNS Drugs;2023-05

3. OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2021-07-05

4. Release Behavior of Telmisartan/Amlodipine Combination Drug According to Polymer Type;Macromolecular Research;2021-03

5. Short and Mid‐Term Predictors of Response to OnabotulinumtoxinA: Real‐Life Experience Observational Study;Headache: The Journal of Head and Face Pain;2020-04